Results 11 to 20 of about 69,025 (166)

Point-of-Care Testing for Hepatitis Viruses: A Growing Need

open access: yesLife, 2023
Viral hepatitis, caused by hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV), or hepatitis E virus (HEV), is a major global public health problem.
Matthew D. Pauly, Lilia Ganova-Raeva
doaj   +1 more source

Serum hepatitis B virus RNA levels as a predictor of HBeAg seroconversion during treatment with peginterferon alfa-2a

open access: yesVirology Journal, 2019
Background Hepatitis B e antigen (HBeAg) seroconversion represents an endpoint of treatment of chronic hepatitis B virus (HBV) infections. Methods We have studied whether levels of serum hepatitis B virus ribonucleic acid (HBV RNA) during pegylated ...
Wen Jia   +8 more
doaj   +1 more source

Chemiluminescent Optical Fiber Immunosensor Combining Surface Modification and Signal Amplification for Ultrasensitive Determination of Hepatitis B Antigen

open access: yesSensors, 2020
Optical fiber based immunosensors are very attractive for biomarker detection. In order to improve the sensor response, we propose a promising strategy which combines porous-layer modification of the fiber surface and streptavidin-biotin-peroxidase nano ...
Xuexue Xu   +3 more
doaj   +1 more source

Are serum quantitative hepatitis b surface antigen levels, liver histopathology and viral loads related in chronic hepatitis b-infected patients?

open access: yesThe Saudi Journal of Gastroenterology, 2016
Background/Aims: Fluctuations in hepatitis B virus (HBV) DNA and alanine transaminase (ALT) levels complicate assessment of the phases of chronic hepatitis B (CHB) infection and correct identification of the inactive HBV carrier state.
Ayhan Balkan   +5 more
doaj   +1 more source

Hepatitis B functional cure and immune response

open access: yesFrontiers in Immunology, 2022
Hepatitis B virus (HBV) is a hepatotropic virus, which damage to hepatocytes is not direct, but through the immune system. HBV specific CD4+ T cells can induce HBV specific B cells and CD8+ T cells.
Jia-Rui Zheng, Zi-Long Wang, Bo Feng
doaj   +1 more source

Correlation Between Quantitative Hepatitis B Surface Antigen and Hepatitis B Virus Deoxyribonucleic Acid Levels in Hepatitis B e Antigen-Positive and Hepatitis B e AntigenNegative Chronic Hepatitis B Patients

open access: yesThe Turkish Journal of Gastroenterology, 2023
This study aimed to analyze the relationship between quantitative hepatitis B surface antigen and hepatitis B virus deoxyribonucleic acid in hepatitis B e antigen-positive and hepatitis B e antigen-negative chronic hepatitis B patients and to determine the best cut-off value for quantitative hepatitis B surface antigen to predict high hepatitis B virus
Viva Finhar Insani Nirmala   +3 more
openaire   +3 more sources

Monoclonal Antibodies Specific for Hepatitis B e Antigen and Hepatitis B Core Antigen

open access: yesHybridoma, 2011
Despite effective vaccination programs in many countries, HBV infection is still a serious health problem throughout the world; more than 2 billion people have been infected with Hepatitis B virus (HBV). The serologic markers are crucial indicators in clinical diagnosis of HBV infection. The persistent presence of anti-HBc is associated with chronicity,
Sogut, Ibrahim   +3 more
openaire   +3 more sources

Seroprevalence of viral hepatitis in riverine communities from the Western Region of the Brazilian Amazon Basin

open access: yesMemorias do Instituto Oswaldo Cruz, 2001
The western region of the Brazilian Amazon Basin has long been shown to be a highly endemic area for hepatitis B and hepatitis D viruses. Data concerning the prevalence of hepatitis C and E viruses in this region are still scarce.
VS de Paula   +3 more
doaj   +1 more source

Anti-hepatitis B virus activity of food nutrients and potential mechanisms of action

open access: yesAnnals of Hepatology, 2023
Hepatitis B virus (HBV) is endemic in many parts of the world and is a significant cause of chronic liver damage and hepatocellular carcinoma. HBV therapeutics vary according to the disease stage.
Alexis Jose-Abrego   +3 more
doaj   +1 more source

Hepatitis B e antigen-negative chronic hepatitis b in Hong Kong [PDF]

open access: yesHepatology, 2000
Hepatitis B e antigen-negative chronic hepatitis B (e−CHB) has been reported in Asia but its prevalence and clinical significance have not been determined. The aims of this study were to determine the prevalence of e−CHB in Hong Kong and the frequency of precore and core promoter mutations in these patients.
Chan, Henry L. Y.   +4 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy